China Pharmaceutical Packaging Industry Report, 2019-2025
|出版日||ページ情報||英文 130 Pages
|中国の医薬品包装産業の分析 China Pharmaceutical Packaging Industry Report, 2019-2025|
|出版日: 2019年05月17日||ページ情報: 英文 130 Pages||
製薬産業の急速な発展に後押しされる形で、中国国内の医薬品パッケージング市場も急速に成長しており、2010～2016年のCAGR (複合年間成長率) は11.2%に達しました。今後も年率10%程度の成長が続き、2021年には市場規模が1400億人民元に達する見通しです。近年の市場の主な傾向として、市場集中度の解消、国内系企業のハイエンド化、生分解性・利便性の高い新型包装材の登場、中性・ホウケイ酸ガラス管への移行などが挙げられます。
Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018, up to RMB107.4 billion, and it will be at least RMB200 billion in 2025 under the impetus of population aging, two-child policy, the boom of biological agents and related favorable policies.
In China, the high-end pharmaceutical packaging market is currently carved up by multinational corporations, typically BD, Gerresheimer, SCHOTT, Nipro and Amcor; Chinese companies just focus on low- and mid-end markets, but they tend to move toward the high-end by lavishing more on research and development as pharmaceutical packaging standards grow stricter.
A total of over 1,500 Chinese pharmaceutical packaging companies fall into three kinds: a handful of pharmaceutical giants that concentrate on independent production, like Sichuan Kelun Pharmaceutical Co., Ltd.; players which not only work on pharmaceutical packaging but have offerings for food, healthcare products and consumer goods packaging, such as Shandong Linuo Technical Glass Co., Ltd., Heilongjiang Tongyu Pharmaceutical Packaging Co., Ltd. and Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.; and those committing themselves to the R&D, production and sales of pharmaceutical packaging materials, for instance, Shandong Pharmaceutical Glass Co., Ltd., Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd., Shanxi Hongguang Medicine Packaging Co., Ltd. and Hebei First Rubbebr Medical Technology Co., Ltd.. In the lowly concentrated pharmaceutical packaging market of China, even the pharmaceutical glass bellwether Shandong Pharmaceutical Glass Co., Ltd. takes a tiny share of 2.4% in 2018.
China's pharmaceutical packaging industry holds the following trends:
China has built a standard system for pharmaceuticals industry over the years. The country pays more and more attention to the stability of pharmaceutical packaging materials during the drug storage period, and safety when used. Under this background, new types of green, degradable and easy-to-use pharmaceutical packaging materials and vessels are in the palmy days.
Mergers and acquisitions among pharmaceutical packaging companies occurred frequently in recent years, thanks to favorable policies like the Guidance on Accelerating the Merger and Reorganization of Enterprises in Key Industries. For instance, Shandong Pharmaceutical Glass Co., Ltd. acquired Sichuan Mianzhu Chengxin Pharmaceutical Glass Co. Ltd.; Anhui BBCA Pharmaceutical Co., Ltd. acquired Chengdu PUSH Pharmaceutical Co., Ltd.; China Jianyin Investment Ltd. (JIC) acquired SGD Pharma; and Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd. acquired Nanchong Sanying Medicinal Packaging Material Co., Ltd., Accordingly, Chinese pharmaceutical packaging market is increasingly concentrated.
As people lead a better life, they require better quality of pharmaceutical packaging materials. A growing number of companies have applied international standard-based neutral borosilicate glass. Several companies including Shandong Pharmaceutical Glass Co., Ltd., Chongqing Zhengchuan Glass Co., Ltd., Cangzhou Four Stars Glass Co., Ltd., Anhui Huaxin Medicinal Glass Products Co., Ltd., Baoji Tongli Pharmaceutical Glass Co., Ltd. and Ningbo Zhengli Pharmaceutical Packing Co., Ltd. have been approved to roll out their neutral borosilicate glass products. Driven by companies that have passed consistency evaluation, neutral borosilicate products will become an alternative to low borosilicate products in China. The injection packaging materials field alone will see RMB3 billion to RMB9 billion be replaced.
China Pharmaceutical Packaging Industry Report, 2019-2025 highlights the following:
China pharmaceutical packaging industry (development status, market size, competitive pattern, import & export, market segments, downstream demand, and development trend);
4 foreign companies (operation, pharmaceutical packaging business, and development in China);
16 Chinese companies (operation, pharmaceutical packaging business, and forecast).